Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
820.00    5.00 (0.61%)
Bid:
810.00
Ask:
820.00
Spread: 10.00 (1.235%)
Market Cap: £133.82m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

Share Purchase

29 Mar 2016 15:58

RNS Number : 4412T
Arbuthnot Banking Group PLC
29 March 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Arbuthnot Banking Group

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Slater Investments Ltd

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

24th March 2016

6. Date on which issuer notified:

29th March 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 3%

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0007922338

291,391

 

291,391

 

0

0

466,391

0%

3.05%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

466,391

3.05%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

J.R. Kaye

15. Contact telephone number:

020 7012 2430

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKVSRNOAOUAR
Date   Source Headline
26th Jul 20181:50 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 1H'18 results: continuing the good work
17th Jul 20187:00 amRNSHalf Year Report
11th Jul 20187:00 amRNSAppointment of New Chief Executive Officer
10th May 20183:26 pmRNSAGM Statement
17th Apr 20183:23 pmRNSBoard Change
4th Apr 201811:15 amRNSHardman & Co: 2017: capital deployed, adding value
28th Mar 20187:00 amRNSFinal Results
22nd Feb 20187:00 amRNSPre close Trading Update
11th Oct 20177:00 amRNSArbuthnot Banking Group 3Q Trading Update
27th Jul 201711:35 amRNSHardman Research: Value added strategy in results
18th Jul 20177:00 amRNSHalf-year Report
4th May 20173:29 pmRNSAnnual General Meeting Statement - 2017
28th Apr 201711:20 amRNSCompletion of Acquisition
30th Mar 20175:03 pmRNSDirector/PDMR Shareholding
28th Mar 20171:29 pmRNSHardman Research: History is repeating itself
23rd Mar 20177:00 amRNSFinal Results for the year to 31 December 2016
21st Feb 20177:00 amRNSPre Close Trading Update
23rd Jan 20175:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20173:27 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:26 pmRNSHardman Research: Clear strategy, value added deal
20th Dec 20165:10 pmRNSAsset Backed Finance Acquisition
19th Dec 20167:00 amRNSLoan Portfolio Acquisition
9th Dec 201611:12 amRNSChange of Adviser
18th Oct 20169:36 amRNSHardman&Co. Special dividend, accelerated investm.
13th Oct 20167:00 amRNSThird Quarter Trading Update
6th Oct 20162:53 pmRNSAppointment of Independent Non-Executive Director
1st Aug 20163:22 pmRNSH&Co: Tripedalism - three legs are better than two
19th Jul 20167:00 amRNSResults for the six months to 30 June 2016
1st Jul 20164:40 pmRNSSecond Price Monitoring Extn
1st Jul 20164:35 pmRNSPrice Monitoring Extension
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
15th Jun 20165:36 pmRNSHolding(s) in Company
15th Jun 20165:22 pmRNSCompletion of sale by Arbuthnot Banking Group PLC
15th Jun 20165:16 pmRNSCompletion of sale
14th Jun 20165:06 pmRNSPhantom Share Option Scheme
14th Jun 201611:16 amRNSResults of General Meeting
10th Jun 20162:51 pmRNSAcqusition of West End Premises
10th Jun 201610:46 amRNSAnnouncement of New Independent NED
27th May 20164:30 pmRNSConditional sale of shares by Arbuthnot
27th May 20164:30 pmRNSConditional sale of shares in Secure Trust Bank
27th May 20167:00 amRNSProposed sale of ordinary shares in Secure Trust
27th May 20167:00 amRNSProposed sale by Arbuthnot of ordinary shares
5th May 20163:28 pmRNSAGM Statement
4th May 20163:20 pmRNSAGM Statement
14th Apr 20163:01 pmRNSBoard Changes
13th Apr 20163:47 pmRNSCompletion of the disposal of Everyday Loans Group
29th Mar 20163:58 pmRNSShare Purchase
21st Mar 20161:43 pmRNSShare Acquisition
17th Mar 20167:00 amRNSFinal Results for the year to 31 December 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.